Balyasny Asset Management »

Aeglea Biotherapeutics shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $6.7M 228k 29.41
2024-06-30 $6.4M 273k 23.51
2024-03-31 $1.2M 32k 37.93